Subtle Medical Expands AI Imaging Solutions with FDA Approval for CT Enhancement Software

Subtle Medical, an innovator in AI-driven medical imaging technology, has received FDA clearance for SubtleHD™(CT), a novel software aimed at enhancing CT imaging quality. This marks a significant expansion of the company's capabilities, previously focused on MRI and PET modalities, to now include CT imaging as part of its comprehensive, multi-modality imaging platform.

SubtleHD(CT) is designed to improve image quality by reducing noise and increasing low-contrast detectability, thereby supporting radiologists with more precise and consistent images. With this clearance, Subtle Medical now offers its 11th FDA-cleared product, enhancing its suite of AI-powered solutions already implemented on over 1,300 imaging systems globally.

CT imaging remains a cornerstone in medical diagnostics, playing a crucial role in the identification and monitoring of various health conditions. As demand for medical imaging continues to escalate, there is an ongoing challenge for healthcare providers to maintain high-quality imaging across diverse equipment, including both new and aging scanners.

To address these challenges, SubtleHD(CT) integrates seamlessly into existing clinical workflows while improving clarity and consistency of imaging results. This development not only maximizes the utility of current scanning infrastructure but also aligns with the company's mission to offer vendor-neutral solutions that enhance operational and diagnostic efficiency.

"Healthcare organizations must strike a balance between technological advancement and infrastructure investment," stated Ohad Arazi, CEO of Subtle Medical. "SubtleHD(CT) leverages our deep expertise in AI image enhancement to support better imaging outcomes across the CT imaging domain."

Ajit Shankarayarayanan, PhD, Chief Product Officer at Subtle Medical, emphasized the software's ability to deliver consistent imaging quality across varying CT systems. This consistency is critical for healthcare providers managing an assortment of scanning technologies within their institutions.

The introduction of SubtleHD(CT) builds on Subtle Medical’s vision of a cohesive AI Imaging Hub, comprising other solutions, including SubtleHD™(MR), SubtleHD™(PET), SubtleSYNTH™, and SubtleALIGN™. Together, these tools aim to improve image quality, optimize workflows, and extend the lifespan and utility of existing imaging infrastructure across modalities.